Archimed Completes Acquisition Of Natus Medical Incorporated For $1.2 Billion Total Equity Value
Acquiring Company
ARCHIMED
Acquired Company
Natus Sensory
MiddletonFinancial ServicesHealth CareVenture CapitalMedicalventure capital & private equityBiotechnologyHealth Caremedical devicesDescription
Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions to screen, diagnose, and treat disorders affecting the brain, neural pathways, and eight sensory nervous systems, announced today that the MED Platform II fund of ArchiMed (“ArchiMed”), a leading investment firm focused exclusively on the healthcare industry, completed the acquisition of Natus. In accordance with the definitive merger agreement, Natus shareholders received $33.50 in cash for each share of Natus common stock.
Quick answer
ARCHIMED is acquiring Natus Sensory for $1.2 billion, announced July 21, 2022.
- How much did ARCHIMED pay for Natus Sensory?
- The reported deal value is $1.2 billion.
- What does ARCHIMED do?
- ARCHIMED is a private equity firm focusing on the healthcare sector.
- Where are ARCHIMED and Natus Sensory based?
- Natus Sensory is based in Middleton, Wisconsin, United States.
- Who are the decision-makers at ARCHIMED?
- Fundz holds 1 contact at ARCHIMED. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Financial Services and Venture Capital
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Bristol Myers Squibb And Turning Point Therapeutics Announce Expiration Of Hsr Act Waiting Period And Clearance From Federal Cartel Office Of Germany Related To Pending Acquisition Of Turning Point Therapeutics (August 16, 2022)
- Gurnet Point Capital And Patient Square Capital Complete Their Acquisition Of Radius Health, Inc. (August 15, 2022)
- Bristol Myers Squibb Completes Acquisition Of Turning Point Therapeutics, Expanding Precision Oncology Portfolio (August 17, 2022)
- Md Office Solutions, Llc, Acquires Antigua Medical Services, Llc; A Cardiac Mobile Imaging Company In Arizona (August 17, 2022)
- Conmed Completes Acquisition Of Biorez, Inc. (August 9, 2022)
- Conmed Announces Definitive Agreement To Acquire Biorez, Inc. (August 1, 2022)
Who to call at ARCHIMED, and when
When ARCHIMED changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day ARCHIMED raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ARCHIMED, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ARCHIMED. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ARCHIMED makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Natus Sensory?
Natus Sensory was acquired by ARCHIMED. The deal was reported on July 21, 2022. ARCHIMED is a private equity firm focusing on the healthcare sector. It invests in and supports companies that provide innovative solutions in medical technology and services. ARCHIMED is privately held and operates in Financial Services.
When did ARCHIMED acquire Natus Sensory?
ARCHIMED's acquisition of Natus Sensory was reported on July 21, 2022. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Natus Sensory do?
Natus Sensory is a global leader in solutions for assessing, fitting, and screening in the areas of hearing, balance, vision, and newborn care. They focus on innovative devices and services that improve patient care and support healthcare professionals. It is privately held, operating in Biotechnology, and is based in Middleton.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.